NBY - PRICE - NovaBay Pharmaceuticals

NovaBay Pharmaceuticals (NBY) is expanding the distribution of Avenova drops through online stores and wholesale retailers. The business relies on close cooperation with pharmacies and specialized medical professionals to distribute anti-infective agents. The company is currently in its maturity stage, developing a cosmetic line, and its indicator stands at . This chart on GURU.Markets clearly demonstrates the current market dynamics of this asset.

The price reflects the market value of a single share, formed through the balance of supply and demand, which allows for the assessment of the business's total capitalization via the asset's market trend. This indicator measures investment expectations, which for NovaBay Pharmaceuticals (NBY) depend directly on the company's ability to maintain margins amid intense pressure from generic manufacturers and high marketing costs.